Corporate News     04-Aug-21
Alkem Laboratories launches Ibuprofen and Famotidine Tablets in US market
Alkem Laboratories (Alkem) today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (US FDA).

Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis® Tablets, 800 mg/26.6 mg. This is the first generic approval of Duexis® Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.

Previous News
  Sensex, Nifty end at record closing highs, Nifty Bank hits all-time high
 ( Market Commentary - Quick Review 25-Jun-24   15:43 )
  Alkem Laboratories to conduct board meeting
 ( Corporate News - 30-Oct-23   16:12 )
  Alkem Laboratories Ltd soars 1.6%, Gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Indices trade with major gains; financial services edge higher
 ( Market Commentary - Mid-Session 25-Jun-24   14:32 )
  Alkem Laboratories to table results
 ( Corporate News - 25-Jan-23   12:07 )
  Alkem Lab completes ISP Chile inspection with no observation
 ( Hot Pursuit - 13-Apr-22   12:04 )
  Alkem Laboratories Ltd gains for third straight session
 ( Hot Pursuit - 07-Dec-23   13:05 )
  Board of Alkem Laboratories appoints director
 ( Corporate News - 14-Sep-22   13:54 )
  Alkem Laboratories Ltd soars 1.23%, rises for third straight session
 ( Hot Pursuit - 25-Nov-20   13:05 )
  Alkem Laboratories to conduct board meeting
 ( Corporate News - 25-Jan-22   10:52 )
  Zydus Lifesciences Ltd Slides 1.88%
 ( Hot Pursuit - 18-Jun-24   09:30 )
Other Stories
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
  Blueblood Ventures schedules board meeting
  01-Oct-24   17:39
  CRISIL to discuss results
  01-Oct-24   17:39
  Indian Renewable Energy Deve. Agency to convene board meeting
  01-Oct-24   17:39
  Ashapuri Gold Ornament schedules board meeting
  01-Oct-24   17:38
  Bijoy Hans to conduct board meeting
  01-Oct-24   17:38
  RS Software (India) to announce Quarterly Result
  01-Oct-24   17:38
Back Top